NAVEEN K MITTAL

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology DALLAS, TX NPI 1114989977

General Payments — all program years on this page

$121,666.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 193
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $17,179.93 across 38 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,133.1212
2019 $23,521.7949
2020 $3,976.585
2021 $107.982
2022 $35,628.0150
2023 $40,118.6737
2024 $17,179.9338

Records — PY2024 (38)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091955587 Ipsen Biopharmaceuticals, Inc $21.19 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091955589 Ipsen Biopharmaceuticals, Inc $28.20 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091955591 Ipsen Biopharmaceuticals, Inc $29.19 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091955593 Ipsen Biopharmaceuticals, Inc $102.59 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091955595 Ipsen Biopharmaceuticals, Inc $25.10 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091955597 Ipsen Biopharmaceuticals, Inc $18.23 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323903 Mirum Pharmaceuticals, Inc. $86.00 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323905 Mirum Pharmaceuticals, Inc. $100.00 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323907 Mirum Pharmaceuticals, Inc. $2,600.00 04/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323909 Mirum Pharmaceuticals, Inc. $65.00 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323911 Mirum Pharmaceuticals, Inc. $41.28 04/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323913 Mirum Pharmaceuticals, Inc. $402.00 04/12/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323915 Mirum Pharmaceuticals, Inc. $116.46 08/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323917 Mirum Pharmaceuticals, Inc. $2,600.00 08/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323919 Mirum Pharmaceuticals, Inc. $69.64 08/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323921 Mirum Pharmaceuticals, Inc. $62.91 08/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323923 Mirum Pharmaceuticals, Inc. $14.30 08/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323925 Mirum Pharmaceuticals, Inc. $2,600.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123323927 Mirum Pharmaceuticals, Inc. $143.48 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323929 Mirum Pharmaceuticals, Inc. $28.26 08/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323931 Mirum Pharmaceuticals, Inc. $118.66 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323933 Mirum Pharmaceuticals, Inc. $32.00 08/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1123323935 Mirum Pharmaceuticals, Inc. $22.71 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323937 Mirum Pharmaceuticals, Inc. $117.39 11/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323939 Mirum Pharmaceuticals, Inc. $147.27 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1123323941 Mirum Pharmaceuticals, Inc. $2,600.00 11/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1123428310 Alcresta Therapeutics, Inc. $15.84 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137636860 Takeda Pharmaceuticals U.S.A., Inc. $16.31 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146950888 Fresenius Kabi USA, LLC $10.81 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146950890 Fresenius Kabi USA, LLC $11.54 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146950892 Fresenius Kabi USA, LLC $18.90 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146950894 Fresenius Kabi USA, LLC $19.97 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146950896 Fresenius Kabi USA, LLC $20.69 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146950898 Fresenius Kabi USA, LLC $122.42 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146950900 Fresenius Kabi USA, LLC $246.14 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146950902 Fresenius Kabi USA, LLC $253.22 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146950904 Fresenius Kabi USA, LLC $502.23 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1146950906 Fresenius Kabi USA, LLC $3,750.00 06/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.